Skip to Content
This high end equipment is installed at Piramal Diagnostics (formerly Wellspring), Mumbai. This facility will offer the new Siemens HD PET technology while providing consistently sharper and clearly defined images across the entire field of view. With the launch of the HD PET-CT, Siemens Medical Solutions is redefining the quality of molecular imaging in India. This state-of-the-art HD PET-CT with Siemens patent technology was inaugurated by Mr. TKA Nair, the Principal Secretary to the Hon. Prime Minister of India.
By utilizing a proprietary reconstruction technique, HD PET can provide distortion-free images throughout the entire field of view. Its improved uniform 2 mm resolution enables physicians to clearly visualize the smallest of lesions from the center to the edges - a benefit unique to Siemens' HD PET. Adding high definition to PET systems also dramatically enhances contrast. The improvement in signal to noise, which effectively doubles, reveals sharper images that allow the clinician to better differentiate between healthy and suspicious tissue.
The HD PET is especially important in monitoring patients who have had surgery or therapy. The image clarity enables physicians to identify the smallest as well as the earliest recurrences of head and neck malignancies, especially in post-operative and post-radiation patients with distorted anatomy. It can provide physicians with improved delineation of early axillary lymph node metastases in primary breast cancer and nodal and chest wall recurrences in post-treatment patients referred for restaging. It is also very useful in lung cancer, especially in post-radiation therapy, post-surgery conditions associated with fibrosis, effusion and pneumonitis. HD PET is based on Siemens' TruePoint technologies - a unique combination of technological features and workflow solutions.
The advantages of high definition with PET imaging means improved clinical outcomes for cancer diagnosis, disease staging, treatment and post-surgery/post-radiation monitoring. In terms of detection, HD PET will improve the smallest abdominal lesions as well as small lymph node metastases including testicular tumors, and cervical and uterine malignancies. HD PET provides improved visualization of small lesions that would otherwise be difficult to image. HD PET can also improve the accuracy of radiotherapy planning because it provides superior detection of the true extent of the lesion.
Speaking at the installation of HD PET-CT, Mr. D Ragavan, Executive Vice President, Siemens Medical Solutions Division, said, “Cardiac and Cancer related disease are two of the major diseases affecting our country. With over one million new patients being diagnosed with cancer every year, there is a greater need to deploy all the innovative technologies to diagnose and to treat patients. HD PET is a clear example of this direction and is a result of rigorous focus on innovation at Siemens. This will definitely help the doctors to understand the disease progress and response to treatment much better than before and will also provide the much needed confidence / comfort to the patients. The global deliveries of HD PET started just a few weeks ago and we are doubly delighted by the fact that this is the first installation of HD PET in Asia”.
About Siemens Healthcare
Siemens Healthcare is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care -- from prevention and early detection, to diagnosis, therapy and care. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion (on a pro forma basis including Dade Behring roughly €11 billion), orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.
About Siemens Ltd
Siemens Ltd is the flagship listed company in India. Siemens in India, which comprises of 19 legal entities, is a leading provider of industry and infrastructure solutions with a business volume aggregating about Rs 11,000 crores. It operates in the core business segments of Energy, Industry Transportation, Healthcare, Information Technology, Communication and Lighting. It has nation-wide Sales and Service network, 18 manufacturing plants, some 500 strong network of channel partners and employs over 18,000 people.